SAN DIEGO, CA—No interventional cardiology meeting would be complete without a debate as to when and in whom cerebral protection is warranted during TAVR procedures. Here at the Society for ...

LONDON, England—Results for the first US-based randomized controlled trial testing use of a cerebral protection device in TAVR are due out next month, but in Europe, where a number of devices already ...

Please provide your email address to receive an email when new articles are posted on . Routine cerebral embolic protection did not reduce stroke in patients undergoing transcatheter aortic valve ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — In PROTECTED TAVR, the largest-ever randomized trial of transcatheter aortic valve replacement, ...

SANTA ROSA, Calif.--(BUSINESS WIRE)--Claret Medical® today announced publication of a new study in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions that ...

A first-of-its kind study found that using a cerebral protection device during transcatheter aortic valve replacement can significantly reduce the number and volume of cerebral lesions in high risk ...

CHICAGO -- Routine use of devices to prevent cerebral emboli during transcatheter aortic valve implantation (TAVI) did not prevent strokes, a large randomized trial showed. Incidence of stroke within ...

Among patients with severe aortic stenosis (narrowing of the aortic valve) undergoing transcatheter aortic valve implantation, the use of a cerebral protection device (a filter that captures debris ...

WASHINGTON--(BUSINESS WIRE)--Claret Medical™, Inc. today announced that the CLEAN-TAVI Trial met its primary endpoint by demonstrating that the company’s cerebral protection system significantly ...